For those on natalizumab infusion in the UK learn the name of this one. Natalizumab from Biogen is out of patent and as we are in poundland Britain, NICE will be telling the neuros to use the biosimilar to save a few pennies. Natalizumab is also known as Tysabri but the biosimilar is called Tyruko and it is known as natalizumab-sntz and is produced by Sandoz, which used to […]
https://multiple-sclerosis-res....earch.org/2024/05/fo